Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024Cancer MedicineOpen Access

Treatment outcome and germline predictive factors of ropeginterferon alpha‐2b in myeloproliferative neoplasm patients

View Full Paper
Ask AI
Bookmark
Share

Authors

CCChih‐Cheng ChenMKMing‐Chung KuoYWYing‐Hsuan Wang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e7101bb6db643587688fa4https://doi.org/10.1002/cam4.7166
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Classification and Personalized Prognosis in Myeloproliferative Neoplasms2018 · 643 citations
  2. 2Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha1992 · 125 citations
  3. 3Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project2013 · 306 citations
  4. 4Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C2015 · 18 citations